Skip to content

Clinical trials

Phase 3 Carcinoma, Bronchogenic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Bronchogenic Phase: Phase 3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20161
20172
20201
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company1
Fundación GECP1
Hoffmann-La Roche1
Jiangsu HengRui Medicine Co., Ltd.1
Qilu Pharmaceutical Co., Ltd.1
Shanghai Gebaide Biotechnology Co., Ltd.1
Shanghai Pulmonary Hospital, Shanghai, China1
University College London Hospitals1
University of Turin, Italy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Bronchogenic9
Carcinoma, Non-Small-Cell Lung8
Lung Diseases8
Thoracic Neoplasms8
Lung Neoplasms7
Neoplasms6
Respiratory Tract Neoplasms6
Bronchial Neoplasms5
Respiratory Tract Diseases5
Neoplasms by Site4

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.